Inhibition of the synthesis of glycosphingolipid by a ceramide analogue (PPMP) in the gastrulation of Bufo arenarum
- PMID: 10857587
- DOI: 10.1017/s0967199400000940
Inhibition of the synthesis of glycosphingolipid by a ceramide analogue (PPMP) in the gastrulation of Bufo arenarum
Abstract
In the present study the role of glycosphingolipids (GSL) in amphibian development was investigated. We analysed the de novo synthesis of neutral GSL and gangliosides through the initial stages of Bufo arenarum embryo development and their participation during gastrulation using 1-phenyl-2-palmitoyl-3-morpholino-1-propanol (PPMP), a potent inhibitor of glucosylceramide synthase. Ganglioside synthesis began at the blastula stage and reached a maximum during gastrulation (stages 10-12) while neutral GSL synthesis showed a slight gradual increase, the former being quantitatively more significant than the latter. Ganglioside synthesis was reduced by 90% while neutral GSL synthesis was inhibited by 65% when embryos at blastula stage were cultured for 24 h in 20 microM PPMP. The depletion of GSL from amphibian embryos induced an abnormal gastrulation in a dose-dependent manner. We found that PPMP had a pronounced effect on development since no embryos exhibited normal gastrulation; their developmental rate either slowed down or, more often, became totally arrested. Morphological analysis of arrested embryos revealed inhibition of the gastrulation morphogenetic movements. Analysis of mesodermal cell morphology in those embryos showed a severe decrease in the number and complexity of cellular extensions such as filopodia and lamellipodia. Mesodermal cells isolated from PPMP-treated embryos had very low adhesion percentages. Our results suggest that glycosphingolipids participate in Bufo arenarum gastrulation, probably through their involvement in cell adhesion events.
Similar articles
-
Participation of the GM1 ganglioside in the gastrulation of anuran amphibian Bufo arenarum.J Exp Zool. 2000 Apr 1;286(5):457-72. doi: 10.1002/(sici)1097-010x(20000401)286:5<457::aid-jez3>3.0.co;2-a. J Exp Zool. 2000. PMID: 10684569
-
Cloning and functional characterization of two key enzymes of glycosphingolipid biosynthesis in the amphibian Xenopus laevis.Dev Dyn. 2008 Jan;237(1):112-23. doi: 10.1002/dvdy.21406. Dev Dyn. 2008. PMID: 18095347
-
Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5.J Virol. 2000 Jul;74(14):6377-85. doi: 10.1128/jvi.74.14.6377-6385.2000. J Virol. 2000. PMID: 10864648 Free PMC article.
-
Agents for the treatment of glycosphingolipid storage disorders.Curr Drug Metab. 2001 Sep;2(3):331-8. doi: 10.2174/1389200013338414. Curr Drug Metab. 2001. PMID: 11513334 Review.
-
Glucosylceramide synthase and glycosphingolipid synthesis.Trends Cell Biol. 1998 May;8(5):198-202. doi: 10.1016/s0962-8924(98)01249-5. Trends Cell Biol. 1998. PMID: 9695839 Review.
Cited by
-
Gangliosides and cholesterol, two major components of the membrane lipid rafts, as new regulatory partners for stress granules assembly.Cell Stress Chaperones. 2025 Jul 19;30(5):100093. doi: 10.1016/j.cstres.2025.100093. Online ahead of print. Cell Stress Chaperones. 2025. PMID: 40691952 Free PMC article.